NCT06825715 Multilevel Intervention for Precision Oncology
| NCT ID | NCT06825715 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Advanced Cancers of the Prostate |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,653 participants |
| Start Date | 2025-07-02 |
| Primary Completion | 2029-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,653 participants in total. It began in 2025-07-02 with a primary completion date of 2029-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers. The 3 components of the intervention are 1: a short educational video for patients, 2: audit and feedback to providers on their Precision Oncology practice patterns, and 3: a change in the electronic medical record to make it easier to order and review results of Precision Oncology tests.
Eligibility Criteria
Inclusion Criteria: * Patients in the VA with cancer of the lung or prostate who are seen in the oncology clinic Exclusion Criteria: * Cancer that did not originate in the prostate or the lung
Contact & Investigator
Daniel J Becker, MD
PRINCIPAL INVESTIGATOR
VA NY Harbor Healthcare System, New York, NY
Frequently Asked Questions
Who can join the NCT06825715 clinical trial?
This trial is open to participants of all sexes, studying Advanced Cancers of the Prostate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06825715 currently recruiting?
Yes, NCT06825715 is actively recruiting participants. Contact the research team at antoinette.vo@va.gov for enrollment information.
Where is the NCT06825715 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06825715 clinical trial?
NCT06825715 is sponsored by VA Office of Research and Development. The principal investigator is Daniel J Becker, MD at VA NY Harbor Healthcare System, New York, NY. The trial plans to enroll 2,653 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.